Cellectis (CLLS) Cash from Investing Activities Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -122.45% |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -245.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -245.99% |
| Dec 31, 2025 | 234.75% |
| Sep 30, 2025 | -115.41% |
| Jun 30, 2025 | 50.47% |
| Mar 31, 2025 | 305.90% |
| Dec 31, 2024 | -22.74% |
| Sep 30, 2024 | 7,544.33% |
| Jun 30, 2024 | -5,916.34% |
| Mar 31, 2024 | -1,642.11% |
| Dec 31, 2023 | -1,759.45% |
| Sep 30, 2023 | -26.05% |
| Jun 30, 2023 | -59.80% |
| Mar 31, 2023 | 119.39% |
| Dec 31, 2022 | 93.47% |
| Sep 30, 2022 | 90.32% |
| Jun 30, 2022 | -111.49% |
| Mar 31, 2022 | -323.45% |
| Dec 31, 2021 | -211.15% |
| Sep 30, 2021 | -207.90% |
| Jun 30, 2021 | 280.75% |
| Mar 31, 2021 | 100.63% |
| Dec 31, 2020 | 497.16% |
| Sep 30, 2020 | 108.83% |
| Jun 30, 2020 | -72.55% |
| Mar 31, 2020 | -989.59% |
| Dec 31, 2019 | -23.14% |
| Sep 30, 2019 | -240.37% |
| Jun 30, 2019 | -115.56% |
| Mar 31, 2019 | -716.12% |
| Dec 31, 2018 | -300.97% |
| Sep 30, 2018 | 199.67% |
| Jun 30, 2018 | 251.36% |
| Mar 31, 2018 | 80.60% |
| Dec 31, 2017 | -101.08% |
| Sep 30, 2017 | -26.43% |
| Jun 30, 2017 | -149.02% |
| Mar 31, 2017 | 97.25% |
| Dec 31, 2016 | 4,938.00% |
| Sep 30, 2016 | 19,818.89% |
| Jun 30, 2016 | -53.97% |
| Mar 31, 2016 | -2,990.07% |